market is expected to grow
at a substantial rate during the forecast period. The India piperacillin/tazobactam
market is driven by use of these drugs for treating various infections such as nosocomial
pneumonia. It is a combinational drug for which the
tazobactam is added to beta-lactam antibiotic piperacillin to make it more
effective against organisms that express beta-lactamase and would normally
degrade piperacillin. Additionally, supportive government
policies and improving healthcare infrastructure are some other reasons that
are expected to create lucrative opportunities for the market growth over the
next few years.
The India piperacillin/tazobactam market
is segmented based on route of administration, distribution channel, source, application, end
user, company and region. Based on
source, the market can be split into in-house and contract manufacturing
organizations. Out of which, the in-house segment dominated the market until
2017 owing to in house production preference by the major market players. The
contract manufacturing organizations segment is expected to witness significant
growth during the forecast period on account of increased outsourcing
activities by major companies in order to focus on their R&D activity and
expansion plans. Additionally, contract manufacturing organizations offer
competitive pricing and can provide bulk orders in lesser duration.
The major players operating in the
India piperacillin/tazobactam market are Aristo Pharmaceuticals Ltd, Radicura
Pharmaceuticals Pvt. Ltd., Tauras Laboratories Pvt. Ltd., Taj Pharmaceuticals
Ltd., Corona Remedies Pvt. Ltd., Bestochem Formulations (India) Pvt. Ltd., Alpa
Laboratories Ltd., Medical
Pharma Ltd., Cipla Ltd., Lupin Laboratories Ltd and others. Major companies are
developing advanced technologies, receiving approvals from regulatory bodies
and launching new products in order to stay competitive in the market. Other
competitive strategies include mergers & acquisitions, research
collaborations and new product developments.
Years considered for this report:
Historical Years: FY2017-FY2020
Base Year: FY2021
Estimated Year: FY2022
Forecast Period: FY2023–FY2027
Objective of the Study:
- To analyze historical growth in market size of India piperacillin/tazobactam
market from FY2017 to FY2021.
- To estimate and forecast the market size of India piperacillin/tazobactam
market from FY2022 to FY2027 and growth rate until FY2027.
- To classify and forecast India piperacillin/tazobactam market based
on route of administration, distribution channel, source, application, end
user, company and regional distribution.
- To identify dominant region or segment in the India piperacillin/tazobactam
- To identify drivers and challenges for India piperacillin/tazobactam
- To examine competitive developments such as expansions, new product
launches, mergers & acquisitions, etc., in India piperacillin/tazobactam
- To identify and analyze the profiles of leading players operating
in India piperacillin/tazobactam market.
- To identify key sustainable strategies adopted by market players in
India piperacillin/tazobactam market.
Click here to download the sample
TechSci Research performed both primary
as well as exhaustive secondary research for this study. Initially, TechSci
Research sourced a list of manufacturers across the globe. Subsequently,
TechSci Research conducted primary research surveys with the identified
companies. While interviewing, the respondents were also enquired about their
competitors. Through this technique, TechSci Research could include the
manufacturers which could not be identified due to the limitations of secondary
research. TechSci Research analyzed the manufacturers, distribution channels
and presence of all major players across the globe.
Research calculated the market size of India piperacillin/tazobactam market using a bottom-up approach,
wherein data for various end-user segments was recorded and forecast for the
future years. TechSci Research sourced these values from the industry experts
and company representatives and externally validated them through analyzing historical
data of these product types and applications for getting an appropriate,
overall market size. Various secondary sources such as company websites, news
articles, press releases, company annual reports, investor presentations and
financial reports were also studied by TechSci Research.
Key Target Audience:
- Piperacillin/tazobactam manufacturers/
- Market research and consulting firms
- Government bodies such as regulating
authorities and policy makers
- Organizations, forums and alliances related to
The study is useful in providing answers to several critical
questions that are important for the industry stakeholders such as
manufacturers, suppliers and partners, end users, etc., besides allowing them
in strategizing investments and capitalizing on market opportunities.
In this report,
India piperacillin/tazobactam market has been segmented into following
categories, in addition to the industry trends which have also been detailed
- India Piperacillin/Tazobactam Market, By Route of Administration:
- India Piperacillin/Tazobactam Market, By Distribution
- India Piperacillin/Tazobactam Market, By Source:
- India Piperacillin/Tazobactam Market, By Application:
- Skin and
Skin Structure Infections
- India Piperacillin/Tazobactam Market, By End User:
- India Piperacillin/Tazobactam Market, By Region:
Company Profiles: Detailed analysis of the major
companies present in India piperacillin/tazobactam market.
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
market is an upcoming report to be released soon. If you wish an early delivery
of this report or want to confirm the date of release, please contact us at [email protected]
- Detailed analysis and
profiling of additional market players (up to five).